BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Isaka Y, Hayashi H, Aonuma K, Horio M, Terada Y, Doi K, Fujigaki Y, Yasuda H, Sato T, Fujikura T, Kuwatsuru R, Toei H, Murakami R, Saito Y, Hirayama A, Murohara T, Sato A, Ishii H, Takayama T, Watanabe M, Awai K, Oda S, Murakami T, Yagyu Y, Joki N, Komatsu Y, Miyauchi T, Ito Y, Miyazawa R, Kanno Y, Ogawa T, Koshi E, Kosugi T, Yasuda Y;  Japanese Society of Nephrology; Japan Radiological Society;  and Japanese Circulation Society Joint Working Group. Guideline on the use of iodinated contrast media in patients with kidney disease 2018. Clin Exp Nephrol. 2020;24:1-44. [PMID: 31709463 DOI: 10.1007/s10157-019-01750-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Sarno G, Montalti R, Giglio MC, Rompianesi G, Tomassini F, Scarpellini E, De Simone G, De Palma GD, Troisi RI. Hepatocellular carcinoma in patients with chronic renal disease: Challenges of interventional treatment. Surg Oncol 2021;36:42-50. [PMID: 33307490 DOI: 10.1016/j.suronc.2020.11.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
2 Bhargava V, Singh K, Meena P, Sanyal R. Nephrogenic systemic fibrosis: A frivolous entity. World J Nephrol 2021; 10(3): 29-36 [PMID: 34136369 DOI: 10.5527/wjn.v10.i3.29] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
3 Moitinho MS, Santos ES, Caixeta AM, Belasco AGDS, Barbosa DA, Fonseca CDD. Contrast-Induced Nephropathy in patients submitted to percutaneous coronary intervention: an integrative review. Rev Bras Enferm 2020;73:e20200190. [PMID: 33338170 DOI: 10.1590/0034-7167-2020-0190] [Reference Citation Analysis]
4 Miao S, Pan C, Li D, Shen S, Wen A. Endorsement of the TRIPOD statement and the reporting of studies developing contrast-induced nephropathy prediction models for the coronary angiography/percutaneous coronary intervention population: a cross-sectional study. BMJ Open 2022;12:e052568. [PMID: 35190425 DOI: 10.1136/bmjopen-2021-052568] [Reference Citation Analysis]
5 Choi M, Lee Y, Jung S. The Image Quality and Diagnostic Performance of CT with Low-Concentration Iodine Contrast (240 mg Iodine/mL) for the Abdominal Organs. Diagnostics 2022;12:752. [DOI: 10.3390/diagnostics12030752] [Reference Citation Analysis]
6 Cho E, Ko GJ. The Pathophysiology and the Management of Radiocontrast-Induced Nephropathy. Diagnostics (Basel) 2022;12:180. [PMID: 35054347 DOI: 10.3390/diagnostics12010180] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Wei X, Chen H, You Z, Yang J, He H, He C, Zheng W, Lin K, Jiang F. Nutritional status and risk of contrast-associated acute kidney injury in elderly patients undergoing percutaneous coronary intervention. Clin Exp Nephrol 2021;25:953-62. [PMID: 33844109 DOI: 10.1007/s10157-021-02061-4] [Reference Citation Analysis]
8 Kao TW, Lee KH, Chan WP, Fan KC, Liu CW, Huang YC. Continuous use of metformin in patients receiving contrast medium: what is the evidence? A systematic review and meta-analysis. Eur Radiol 2021. [PMID: 34837099 DOI: 10.1007/s00330-021-08395-7] [Reference Citation Analysis]
9 Yoshida R, Usui K, Katsunuma Y, Honda H, Hatakeyama K. Reducing contrast dose using virtual monoenergetic imaging for aortic CTA. J Appl Clin Med Phys 2020;21:272-7. [PMID: 32614147 DOI: 10.1002/acm2.12951] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Ali ZA, Escaned J, Dudek D, Radhakrishnan J, Karimi Galougahi K. Strategies for Renal Protection in Cardiovascular Interventions. Korean Circ J 2022;52:485. [DOI: 10.4070/kcj.2022.0093] [Reference Citation Analysis]